Content related to Looking Ahead: A New Frontier in Retinoblastoma

Jesse Berry, MD, shares how CHLA’s pioneering liquid biopsy is personalizing care for retinoblastoma.

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

Children’s Hospital Los Angeles researchers develop a pediatric solid tumor liquid biopsy for use when obtaining a tissue biopsy is not feasible.

CHLA has been at the forefront of retinoblastoma research for decades. Cobrinik was invited to review the current state of retinoblastoma research.

The Summer Oncology Research Fellowship (SORF) at Children’s Hospital Los Angeles and USC encourages medical students from around the nation to pursue research.

A Chuck Lorre Research Scholar reflects on her time at CHLA.

Jeannie used CHLA’s Online Second Opinion program to receive prompt, personalized recommendations for her daughter’s retinoblastoma treatment.

A more aggressive treatment regimen for clear cell sarcoma has transformed survival rates for children with the disease.